Zobrazeno 1 - 10
of 734
pro vyhledávání: '"drug-resistant TB"'
Autor:
Teyim Pride Mbuh, Patricia Mendjime, Irene-Adeline Goupeyou-Wandji, Valerie Flore Donkeng-Donfack, Judith Kahou, Laurent-Mireille Endale Mangamba, Severin Mefoug, Patricia Annie Bisso Ngono, Linda Esso, Georges Alain Etoundi Mballa
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Introduction Tuberculosis(TB), currently has limited treatment options, and faces worldwide threat of drug-resistance(DR). In 2022, the DR-TB prevalence in Cameroon was 1.4% among new-cases and 8.3% among retreatment-cases. We analyzed the D
Externí odkaz:
https://doaj.org/article/5edbe465edea4600a1a443d502855046
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 39, Iss , Pp 175-183 (2024)
Objectives: Drug resistance in tuberculosis (TB) is a very important public health threat that should not be ignored. Understanding the gender, age, and characteristics of individuals affected by TB (without HIV, diabetes, or hepatitis B complication
Externí odkaz:
https://doaj.org/article/939bdf1603ca462b87487d5efe41e7e0
Autor:
Togolani Maya, Aman Wilfred, Clara Lubinza, Saidi Mfaume, Maryjeska Mafie, Daphne Mtunga, Amri Kingalu, Nicodem Mgina, Pammla Petrucka, Basra E. Doulla, Esther Ngadaya, Sayoki G. Mfinanga, Nicholaus P. Mnyambwa
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-6 (2024)
Abstract Introduction Early diagnosis of tuberculosis (TB) and universal access to drug-susceptibility testing (DST) are critical elements of the WHO End TB Strategy. Current rapid tests (e.g., Xpert® MTB/RIF and Ultra-assays) can detect rifampicin
Externí odkaz:
https://doaj.org/article/344320b3678246a58586544b444f0de0
Autor:
M.B. Kaelin, S. Wieser, B. Preiswerk, P.W. Schreiber, D. Russenberger, P. Kaiser, B. Schulthess, J. Nemeth
Publikováno v:
Public Health Action, Vol 14, Iss 2, Pp 51-55 (2024)
The occurrence of transient culture positivity for Mycobacterium tuberculosis (MTB), known as mirage de tuberculose, poses significant challenges in understanding its spectrum and implications. Here, we report a case of transient culture positivity,
Externí odkaz:
https://doaj.org/article/4fe626ea7c2947f288862ce5a2daa14e
Autor:
Bernhard Kerschberger, Michelle Daka, Bhekiwe Shongwe, Themba Dlamini, Siphiwe Ngwenya, Clara Danbakli, Bheki Mamba, Bongekile Nxumalo, Joyce Sibanda, Sisi Dube, Lindiwe Mdluli Dlamini, Edwin Mabhena, Esther Mukooza, Iona Crumley, Iza Ciglenecki, Debrah Vambe
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background Video-enabled directly observed therapy (video-DOT) has been proposed as an additional option for treatment provision besides in-person DOT for patients with drug-resistant TB (DRTB) disease. However, evidence and implementation e
Externí odkaz:
https://doaj.org/article/b5d73a5ca7eb40f8a1e49e1420a11dda
Publikováno v:
Journal of Infection and Public Health, Vol 17, Iss 9, Pp 102522- (2024)
Background: Despite the introduction of bedaquiline (Bdq) containing all-oral regimens for treating patients with rifampicin resistant/multidrug resistant tuberculosis (MDR/RR-TB) in 2019, data on its effectiveness in Pakistan, which has the fifth hi
Externí odkaz:
https://doaj.org/article/bc60401301034584bb41806902f3ea91
Autor:
Kizito Omona, Christopher Ogwang
Publikováno v:
Cogent Public Health, Vol 11, Iss 1 (2024)
Abstract: Multidrug-resistant tuberculosis (MDR-TB) is a major public health hazard on a global scale. It is a kind of tuberculosis (TB) infection produced by bacteria resistant to at least two of the most effective first-line anti-tuberculosis (anti
Externí odkaz:
https://doaj.org/article/ffec75eac1314292bab7720f1d9b0cee
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
PurposeThis study examined the patterns and frequency of genetic changes responsible for resistance to first-line (rifampicin and isoniazid), fluoroquinolones, and second-line injectable drugs in drug-resistant Mycobacterium tuberculosis (MTB) isolat
Externí odkaz:
https://doaj.org/article/3b8bf680b67f48d2a28e5dccc57854e9
Determining the risk-factors for molecular clustering of drug-resistant tuberculosis in South Africa
Autor:
Halima Said, Elizabeth Kachingwe, Yasmin Gardee, Zaheda Bhyat, John Ratabane, Linda Erasmus, Tiisetso Lebaka, Minty van der Meulen, Thabisile Gwala, Shaheed Omar, Farzana Ismail, Nazir Ismail
Publikováno v:
BMC Public Health, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Drug-resistant tuberculosis (DR-TB) epidemic is driven mainly by the effect of ongoing transmission. In high-burden settings such as South Africa (SA), considerable demographic and geographic heterogeneity in DR-TB transmission ex
Externí odkaz:
https://doaj.org/article/ed1ccb236c794503905da4d74aab6e2b
Autor:
Rita Makabayi-Mugabe, Joseph Musaazi, Stella Zawedde-Muyanja, Enock Kizito, Katherine Fatta, Hellen Namwanje-Kaweesi, Stavia Turyahabwe, Abel Nkolo
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Health facility-based directly observed therapy (HF DOT) is the main strategy for the management of patients with drug-resistant tuberculosis (DR TB) in Uganda, however, this still yields sub-optimal treatment outcomes. We set out
Externí odkaz:
https://doaj.org/article/d1795c8ec2c84e28ae9dfe9483fded67